Clinical trialNCT03001128CompletedObservational

Biomarkers to Predict Time to Plasma HIV RNA Rebound

SponsorAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsEnrollment61HIV-1 Infection

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to collect information about what happens when people pause, or temporarily stop taking, ART, and to collect blood samples from these people at frequent intervals. We will also study the safety of pausing ART under close observation.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

David Smith, MD, MAS
University of California San Diego AVRC CRS
Study Chair
clinicaltrials.gov ↗
Jonathan Li, MD, MMS
Brigham and Women's Hospital ACTG CRS
Study ChairKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Puerto Rico

5401 Puerto Rico Aids Clinical Trials Unit Crs
San Juan, PR, Puerto Rico

Thailand

31802 Thai Red Cross Aids Research Centre (trc-Arc) Crs
Bangkok, Patumwan, Thailand

United States

601 University of California, Los Angeles Care Center Crs
Los Angeles, California, United States
701 University of California, San Diego Antiviral Research Center Crs
San Diego, California, United States
801 University of California, San Francisco Hiv/aids Crs
San Francisco, California, United States
University of Colorado Hospital Crs (6101)
Aurora, Colorado, United States
Whitman Walker Health Crs (31791)
Washington D.C., District of Columbia, United States
2701 Northwestern University Crs
Chicago, Illinois, United States
Rush Univ. Med. Ctr. Actg Crs (2702)
Chicago, Illinois, United States
101 Massachusetts General Hospital (mgh) Crs
Boston, Massachusetts, United States
107 Brigham and Women'S Hosp. Actg Crs
Boston, Massachusetts, United States
Washington U Crs (2101)
St Louis, Missouri, United States
University of Rochester Adult Hiv Therapeutic Strategies Network Crs (31787)
Rochester, New York, United States
3201 Chapel Hill Crs
Chapel Hill, North Carolina, United States
3203 Greensboro Crs
Greensboro, North Carolina, United States
Pittsburgh Crs (1001)
Pittsburgh, Pennsylvania, United States
3652 Vanderbilt Therapeutics (vt) Crs
Nashville, Tennessee, United States
31443 Trinity Health and Wellness Center Crs
Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Antiretroviral treatment pause

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 23 Feb 2017
Primary completion: 29 Jan 2021
Completion: 29 Jan 2021
Last update posted: 13 Dec 2024
Registered enrollment: 61
Registry id: NCT03001128

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.